Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Systemic Lupus Erythematosus Associated with Ovarian Cancer.

Yagita M, Hata S, Miyata H, Kakita H, Tsukamoto T, Muso E, Fujita M.

Intern Med. 2019 Mar 1;58(5):731-735. doi: 10.2169/internalmedicine.1736-18. Epub 2018 Oct 17.

2.

Synthesis and Evaluation of Antibacterial Activity of Bottromycins.

Yamada T, Yagita M, Kobayashi Y, Sennari G, Shimamura H, Matsui H, Horimatsu Y, Hanaki H, Hirose T, O Mura S, Sunazuka T.

J Org Chem. 2018 Jul 6;83(13):7135-7149. doi: 10.1021/acs.joc.8b00045. Epub 2018 Apr 16.

PMID:
29560726
3.

Hypertrophic Pachymeningitis in Sjögren's Syndrome.

Nakano Y, Yamamoto M, Komatsu K, Yagita M, Fujita M.

Intern Med. 2018 Feb 1;57(3):413-415. doi: 10.2169/internalmedicine.9406-17. Epub 2017 Nov 1.

4.

Dermatomyositis Associated with Lung Neuroendocrine Carcinoma.

Takashima R, Takamatsu K, Shinkawa Y, Yagita M, Fukui M, Fujita M.

Intern Med. 2017;56(6):719-724. doi: 10.2169/internalmedicine.56.7768. Epub 2017 Mar 17.

5.

Successful treatment of prokinetic-resistant intestinal pseudo-obstruction and pneumatosis cystoides intestinalis in systemic sclerosis with metronidazole.

Fujita M, Nakano Y, Yagita M.

Rheumatol Int. 2017 Jul;37(7):1213-1215. doi: 10.1007/s00296-017-3668-7. Epub 2017 Feb 17. No abstract available.

PMID:
28213637
6.

Intravascular large B-cell lymphoma with a high titer of proteinase-3-anti-neutrophil cytoplasmic antibody mimicking granulomatosis with polyangiitis.

Shinkawa Y, Hatachi S, Yagita M.

Mod Rheumatol. 2019 Jan;29(1):195-197. doi: 10.1080/14397595.2016.1205798. Epub 2016 Jul 11.

PMID:
27398728
7.

Successful treatment of refractory giant cell arteritis with etanercept.

Fujita M, Tabuchi Y, Yagita M.

Rheumatol Int. 2016 Aug;36(8):1177-9. doi: 10.1007/s00296-016-3521-4. Epub 2016 Jul 1. No abstract available.

PMID:
27368671
8.

Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis.

Tsujimoto K, Hata A, Fujita M, Hatachi S, Yagita M.

Int J Rheum Dis. 2018 Jul;21(7):1406-1413. doi: 10.1111/1756-185X.12899. Epub 2016 Jun 13.

PMID:
27291096
9.

Atypical Presenting Symptoms of Acute Onset Systemic Lupus Erythematosus with Enteritis and Cystitis.

Yagita M, Tsujimoto K, Yagita M, Fujita M.

Case Rep Med. 2016;2016:8579812. doi: 10.1155/2016/8579812. Epub 2016 Mar 15.

10.

Successful Use of Plasma Exchange in the Treatment of Corticosteroid-Refractory Eosinophilic Granulomatosis with Polyangiitis Associated with Gastrointestinal Manifestations.

Tsujimoto K, Yagita M, Taniguchi M, Fujita M.

Case Reports Immunol. 2016;2016:8341751. doi: 10.1155/2016/8341751. Epub 2016 Feb 17.

11.

Peripheral neuropathies during biologic therapies.

Yagita M, Hamano T, Hatachi S, Fujita M.

Mod Rheumatol. 2016;26(2):288-93. doi: 10.3109/14397595.2013.859770. Epub 2013 Dec 9.

PMID:
24313920
12.

Reversible IgA deficiency after severe Gram-negative bacteria infection in a patient with systemic sclerosis.

Yagita M, Yasui K, Hori Y, Kimura T.

Mod Rheumatol. 2011 Apr;21(2):197-202. doi: 10.1007/s10165-010-0360-0. Epub 2010 Sep 28.

PMID:
20878343
13.

CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy.

Hatachi S, Kunitomi A, Aozasa K, Yagita M.

Mod Rheumatol. 2010 Oct;20(5):500-5. doi: 10.1007/s10165-010-0300-z. Epub 2010 May 1.

PMID:
20437072
14.

A Case of Transient ACTH Deficiency Associated with Polymyalgia Rheumatica.

Nishi H, Nishi Y, Yagita M, Tamaru Y, Matsumoto S, Koshiyama H.

Jpn Clin Med. 2010 Dec 19;1:25-7. doi: 10.4137/JCM.S6215. eCollection 2010.

15.

Acute Chlamydia pneumoniae infection in the pathogenesis of autoimmune diseases.

Fujita M, Hatachi S, Yagita M.

Lupus. 2009 Feb;18(2):164-8. doi: 10.1177/0961203308096069.

PMID:
19151119
16.

Dermatomyositis associated with thyroid cancer.

Fujita M, Hatachi S, Yagita M.

Rheumatol Int. 2008 Dec;29(2):203-5. doi: 10.1007/s00296-008-0642-4. Epub 2008 Jul 30.

PMID:
18665364
17.

Reversible posterior leukoencephalopathy syndrome in a patient with Takayasu arteritis.

Fujita M, Komatsu K, Hatachi S, Yagita M.

Mod Rheumatol. 2008;18(6):623-9. doi: 10.1007/s10165-008-0097-1. Epub 2008 Jun 28.

PMID:
18587526
18.

Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis.

Uemura M, Fujimura Y, Matsumoto M, Ishizashi H, Kato S, Matsuyama T, Isonishi A, Ishikawa M, Yagita M, Morioka C, Yoshiji H, Tsujimoto T, Kurumatani N, Fukui H.

Thromb Haemost. 2008 Jun;99(6):1019-29. doi: 10.1160/TH08-01-0006.

PMID:
18521503
19.

Immunohistochemically proven cytomegalovirus gastrointestinal diseases in three patients with autoimmune diseases.

Fujita M, Hatachi S, Yagita M.

Clin Rheumatol. 2008 Aug;27(8):1057-9. doi: 10.1007/s10067-008-0846-8. Epub 2008 Feb 12.

PMID:
18266021
20.

Uneventful splenectomy and cholecystectomy in a patient treated with anti-interleukin-6 receptor antibody therapy.

Ishizaki M, Sasada T, Kunitomi A, Konaka Y, Yagita M, Gunji S, Kanai M, Nishimoto N, Takabayashi A.

Langenbecks Arch Surg. 2008 May;393(3):423-5. Epub 2007 Aug 17.

PMID:
17703320
21.
22.

Hypersensitivity to mosquito bites as a potential sign of mantle cell lymphoma.

Kunitomi A, Konaka Y, Yagita M.

Intern Med. 2005 Oct;44(10):1097-9.

23.

Development of ADAMTS13 inhibitor in a patient with hepatitis C virus-related liver cirrhosis causes thrombotic thrombocytopenic purpura.

Yagita M, Uemura M, Nakamura T, Kunitomi A, Matsumoto M, Fujimura Y.

J Hepatol. 2005 Mar;42(3):420-1. No abstract available.

PMID:
15710227
24.

Humanized anti-interleukin 6 receptor antibody induced long-term remission in a patient with life-threatening refractory autoimmune hemolytic anemia.

Kunitomi A, Konaka Y, Yagita M, Nishimoto N, Kishimoto T, Takatsuki K.

Int J Hematol. 2004 Oct;80(3):246-9.

PMID:
15540899
25.

Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.

Okamura T, Kishimoto T, Inoue M, Honda M, Yamashita N, Wakiguchi H, Yagita M, Hosoi G, Sako M, Yasui M, Yagi K, Kawa K.

Bone Marrow Transplant. 2003 Jan;31(2):105-11.

PMID:
12621491
26.

Successful allogeneic stem cell transplantation from an unrelated donor for aggressive Epstein-Barr virus-associated clonal T-cell proliferation with hemophagocytosis.

Yagita M, Iwakura H, Kishimoto T, Okamura T, Kunitomi A, Tabata R, Konaka Y, Kawa K.

Int J Hematol. 2001 Dec;74(4):451-4.

PMID:
11794703
27.

[Intravascular large B-cell lymphoma associated with hypoalbuminemia and hypoxemia].

Yagita M, Tabata R, Konaka Y, Ohno T, Takatsuki K.

Rinsho Ketsueki. 2000 Nov;41(11):1189-94. Japanese.

PMID:
11193438
28.

A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation.

Yagita M, Huang CL, Umehara H, Matsuo Y, Tabata R, Miyake M, Konaka Y, Takatsuki K.

Leukemia. 2000 May;14(5):922-30.

PMID:
10803526
29.

Distinct genetic involvement of the TP53 gene in therapy-related leukemia and myelodysplasia with chromosomal losses of Nos 5 and/or 7 and its possible relationship to replication error phenotype.

Horiike S, Misawa S, Kaneko H, Sasai Y, Kobayashi M, Fujii H, Tanaka S, Yagita M, Abe T, Kashima K, Taniwaki M.

Leukemia. 1999 Aug;13(8):1235-42.

PMID:
10450752
30.

[Extramedullary relapse in the external auditory canal in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid and autologous peripheral blood stem cell transplantation].

Yagita M, Onishi R, Yamagata N, Shimazaki C, Kudoh H, Kobayashi M, Hikiji K, Konaka Y.

Rinsho Ketsueki. 1998 Sep;39(9):709-15. Review. Japanese.

PMID:
9796408
31.

Enhancement of cytolytic activity of human peripheral blood lymphocytes by sodium periodate (IO4) possible involvement of protein kinase C.

Noda I, Fujieda S, Saito H, Saito T, Otsubo T, Yagita M.

Int J Immunopharmacol. 1998 Jan-Mar;20(1-3):15-27.

PMID:
9717079
32.

Therapy-related leukemia and myelodysplasia following oral administration of etoposide for recurrent breast cancer.

Yagita M, Ieki Y, Onishi R, Huang CL, Adachi M, Horiike S, Konaka Y, Taki T, Miyake M.

Int J Oncol. 1998 Jul;13(1):91-6.

PMID:
9625808
33.

MRP-1/CD9 and KAI1/CD82 expression in normal and various cancer tissues.

Huang C, Taki T, Adachi M, Yagita M, Sawada S, Takabayashi A, Inufusa H, Yoshie O, Miyake M.

Int J Oncol. 1997 Nov;11(5):1045-51.

PMID:
21528303
34.

Heat shock enhances the susceptibility of tumor cells to lysis by lymphokine-activated killer cells.

Fujieda S, Noda I, Saito H, Hoshino T, Yagita M.

Arch Otolaryngol Head Neck Surg. 1995 Sep;121(9):1009-14.

PMID:
7646852
35.

[Differential diagnosis of a case of adult-onset Still's disease from bacterial meningitis].

Nakano Y, Yagita M, Araki H, Fujita M, Konaka Y.

Nihon Naika Gakkai Zasshi. 1995 Feb 10;84(2):287-9. Japanese. No abstract available.

PMID:
7722395
36.

Relationship between cellular glutathione level and susceptibility to LAK killing in human pharyngeal carcinoma cell line.

Noda I, Fujieda S, Saito H, Tanaka N, Sugimoto C, Hoshino T, Yagita M.

Anticancer Res. 1994 May-Jun;14(3A):1117-20.

PMID:
8074461
37.

Swainsonine augments the cytotoxicity of human lymphokine-activated killer cells against autologous thyroid cancer cells.

Fujieda S, Noda I, Saito H, Hoshino T, Yagita M.

Arch Otolaryngol Head Neck Surg. 1994 Apr;120(4):389-94.

PMID:
8166967
39.
40.

The presence of concanavalin-A(Con-A)-like molecules on natural-killer (NK)-sensitive target cells: their possible role in swainsonine-augmented human NK cytotoxicity.

Yagita M, Noda I, Maehara M, Fujieda S, Inoue Y, Hoshino T, Saksela E.

Int J Cancer. 1992 Oct 21;52(4):664-72.

PMID:
1399150
41.

Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and tumor-infiltrating lymphocytes activated by PSK.

Kariya Y, Okamoto N, Fujimoto T, Inoue N, Kihara T, Sugie K, Yagita M, Kanzaki H, Mori T, Uchida A.

Jpn J Cancer Res. 1991 Sep;82(9):1044-50.

42.

Prediction of postoperative clinical course by autologous tumor-killing activity in lung cancer patients.

Uchida A, Kariya Y, Okamoto N, Sugie K, Fujimoto T, Yagita M.

J Natl Cancer Inst. 1990 Nov 7;82(21):1697-701.

PMID:
2231757
43.
44.

Soluble factor in normal tissues that stimulates high-molecular-weight sialoglycoprotein production by human colon carcinoma cells.

Irimura T, McIsaac AM, Carlson DA, Yagita M, Grimm EA, Menter DG, Ota DM, Clary KR.

Cancer Res. 1990 Jun 1;50(11):3331-8.

45.
46.

Suppression of human natural killer cell activity by amino sugars.

Yagita M, Nakajima M, Saksela E.

Cell Immunol. 1989 Aug;122(1):83-95.

PMID:
2752431
47.

Involvement of both Tac and non-Tac interleukin 2-binding peptides in the interleukin 2-dependent proliferation of human tumor-infiltrating lymphocytes.

Yagita M, Itoh K, Tsudo M, Schaub LB, Platsoucas CD, Balch CM, Grimm EA.

Cancer Res. 1989 Mar 1;49(5):1154-9.

48.
49.

Lymphokine-activated killer cells. Induction and function.

Grimm EA, Owen-Schaub LB, Loudon WG, Yagita M.

Ann N Y Acad Sci. 1988;532:380-6. Review. No abstract available.

PMID:
3140701
50.

Current understanding of the lymphokine-activated killer cell phenomenon.

Yagita M, Grimm EA.

Prog Exp Tumor Res. 1988;32:213-26. Review. No abstract available.

PMID:
3131833

Supplemental Content

Loading ...
Support Center